Loading…
This event has ended. Visit the official site or create your own event on Sched.
Welcome to the Science Summit at the United Nations General Assembly (UNGA77)

Please Register by clicking HERE

Registration is free of charge. You can register yourself and also other colleagues (up to 10 people).

After you have registered, you will receive two emails: one from Eventbrite with your ticket, and 15 min later, one from SCHED inviting you to create your username and password (these will be your  SCHED login details to access the conference each time).

Once you have your SCHED login details, you can select the session(s) you would like to attend and be able to see the ZOOM link to join your selected sessions.

All times in the AGENDA are New York Local (Eastern Daylight Time (EDT)). To view times in another time zone, please use the "Timezone" box located below on the right.
Back To Schedule
Thursday, September 29 • 8:00am - 9:30am
(REF 29026) Achieving Health for All and Meeting the Sustainable Development Goals Through Inclusive Research and Development and Equitable Access: Best Practices and Lessons Learned

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Feedback form is now closed.
Add to your schedule to access the video stream
Nearly three years after the start of the COVID-19 pandemic, the critical importance of investing in biomedical research and development (R&D) to achieve Health for All has become more apparent than ever. New, effective vaccines were developed with unprecedented speed thanks to a level of global investment and collaboration in R&D that matched the urgency of the crisis. However, these remarkable efforts also exposed serious gaps in equitable access to health tools, technologies, and services, which have had a negative impact on key areas of development. The lesson is clear: investing in both biomedical innovation and equitable access is necessary to achieve Health for All, which in turn is a driver for sustainable development. Join us for an interactive discussion on how good practices in innovation are contributing to the achievement of the third Sustainable Development Goal, and the solutions needed to support sustainable and expanded scientific collaborations. The session will end with a Q&A.

This event is co-organized by Drugs for Neglected Diseases initiative, Medicines for Malaria Venture, and TB Alliance.
Moderator
avatar for Boghuma Kabisen Titanji

Boghuma Kabisen Titanji

Assistant Professor of Medicine, Emory University
Boghuma Kabisen Titanji is a Cameroonian born physician-scientist and Assistant Professor of Medicine at Emory University in Atlanta. She obtained her MD from the University of Yaoundé I in Cameroon where she worked as a medical officer after graduating, before pursuing postgraduate... Read More →

Speakers
avatar for Andrea Lucard

Andrea Lucard

Executive Vice-President, Medicines for Malaria Venture
Andrea is the Executive Director of Corporate Affairs at Medicines for Malaria Venture. In addition to leading donor relations, communications, and advocacy for MMV, she also runs the operational and cross-functional teams connecting MMV’s business model to its organizational impact... Read More →
avatar for Soumya Swaminathan

Soumya Swaminathan

Chief Scientist, World Health Organization (WHO)
Dr Soumya Swaminathan is Chief Scientist at the World Health Organization (WHO). She previous served as WHO's Deputy Director-General for Programmes. A paediatrician from India and a globally recognized researcher on tuberculosis and HIV, she brings with her 30 years of experience... Read More →
avatar for Anna Doubell

Anna Doubell

COO, Policy Cures Research
Anna is the Chief Operating Officer and Director of Data, Systems and Operations at Policy Cures Research, an independent global health research and policy organisation that is responsible for the G-FINDER project, which reports annually on the state of funding for R&D for neglected... Read More →
avatar for Norbert Ndjeka

Norbert Ndjeka

Chief Director of TB Control and Management, National Department of Health, South Africa
Dr. Norbert Ndjeka has been the Director, Drug-Resistant TB, TB & HIV at the National Department of Health in South Africa since May 2009. His vision is to strengthen the programmatic and clinical management of Drug-Resistant TB (DR-TB). Under his leadership, there has been a decline... Read More →
avatar for Mel Spigelman

Mel Spigelman

President and CEO, TB Alliance
Dr. Spigelman is the President and Chief Executive Officer of the Global Alliance for TB Drug Development (TB Alliance), and a Member of its Board of Directors. Prior to being appointed President and CEO in 2009, Dr. Spigelman served for five and a half years as the Director of Research... Read More →
avatar for Luis Pizarro

Luis Pizarro

Executive Director, Drugs for Neglected Diseases initative
Dr Luis Pizarro has led the Drugs for Neglected Diseases initiative (DNDi) since September 2022. He joined DNDi in June 2022 as Special Advisor and incoming Executive Director.Dr Pizarro is a medical doctor and global health leader. He also serves as founder and member of the Global... Read More →
avatar for Osamu Kunii

Osamu Kunii

CEO, Global Health Innovative Technology Fund (GHIT Fund)
Dr. Osamu Kunii, MD, Ph.D., MPH, is currently serving as CEO and Executive Director of the Global Health Innovative Technology Fund (GHIT), which promotes R&D of therapeutics, diagnostics and vaccines against infectious diseases such as neglected tropical diseases, tuberculosis and... Read More →
avatar for Marcus Vinícius Guimarães de Lacerda

Marcus Vinícius Guimarães de Lacerda

Infectious Disease Physician and Public Health Specialist, Tropical Medicine Foundation Dr. Heitor Vieira Dourado (FMT- HVD) and Leônidas and Maria Deane Institute (ILMD/Fiocruz Amazonia)
Marcus Lacerda is a practicing physician, expert in Infectious Diseases, at the Tropical Medicine Foundation Dr. Heitor Vieira Dourado, researcher with Leônidas and Maria Deane Institute, professor of the Graduate Program on Tropical Medicine (Amazonas State University) and adjunct... Read More →
avatar for Radha Rangarajan

Radha Rangarajan

Director, Central Drug Research Institute, Council of Scientific and Industrial Research, Uttar Pradesh, India
Dr Radha Rangarajan has been actively involved in translational research and product development in the public health arena for the last two decades. Working closely at the interface between academia, start-ups and industry, her experiences span the drug discovery, diagnostics and... Read More →
avatar for Maurine Murenga

Maurine Murenga

Executive Director, Lean On Me Foundation
Maurine has been living with HIV openly since the early 2000s. At that time, there was little access to treatment in Kenya and a lot of stigma around the disease. In 2002, she was expecting her first child, but could not access vertical transmission services; her son contracted HIV... Read More →

Thursday September 29, 2022 8:00am - 9:30am EDT
Online
  Health and Medicine, Policy

Attendees (220)